Ann‐Britt Nygaard
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
- Cancer-related molecular mechanisms research 2
-
- RNA regulation and disease 2
- Co-authors
- Sofie Sølvsten Sørensen (3 shared papers)Thomas Christensen (3 shared papers)Bodil Langbakk (1 shared paper)Bertil Romner (1 shared paper)Mads Bak (1 shared paper)Niels H. H. Heegaard (1 shared paper)Anting Liu Carlsen (1 shared paper)György Sölétormos (3 shared papers)
In The Last Decade
Ann‐Britt Nygaard
7 papers receiving 432 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 268
- Neurology 54
- Neurology 66
- Molecular Biology 278
- Physiology 41
Countries citing papers authored by Ann‐Britt Nygaard
This map shows the geographic impact of Ann‐Britt Nygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Britt Nygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Britt Nygaard more than expected).
Fields of papers citing papers by Ann‐Britt Nygaard
This network shows the impact of papers produced by Ann‐Britt Nygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Britt Nygaard. The network helps show where Ann‐Britt Nygaard may publish in the future.
Co-authors
The 16 scholars most cited alongside Ann‐Britt Nygaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 134 | |
| 2 | 2014 | 128 | |
| 3 | 2017 | 68 | |
| 4 | 2015 | 46 | |
| 5 | 1998 | 44 | |
| 6 | 2013 | 16 | |
| 7 | 2014 | 1 | |
| 8 | Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients | 2015 | 0 |
About Ann‐Britt Nygaard
Ann‐Britt Nygaard is a scholar working on Cancer Research, Molecular Biology, Oncology, Biomedical Engineering and Pathology and Forensic Medicine, having authored 8 papers that have together received 437 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA regulation and disease (2 papers), 3D Printing in Biomedical Research (2 papers), Cancer Treatment and Pharmacology (1 paper) and Spine and Intervertebral Disc Pathology (1 paper). The work is most often cited by research in Cancer Research (268 citations), Neurology (54 citations), Neurology (66 citations), Molecular Biology (278 citations) and Physiology (41 citations). Ann‐Britt Nygaard has collaborated with scholars based in Denmark and Norway. Frequent co-authors include Sofie Sølvsten Sørensen, Thomas Christensen, Bodil Langbakk, Bertil Romner, Mads Bak, Niels H. H. Heegaard, Anting Liu Carlsen, György Sölétormos, Thore Hillig and Ivan Brandslund. Their work appears in journals such as Biomarker Research, Translational Stroke Research, Scandinavian Journal of Clinical and Laboratory Investigation, Apmis and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.